Bank of New York Mellon’s Lunai Bioworks Inc. Common Stock RENB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.47K | Sell |
12,001
-228,243
| -95% | -$65.9K | ﹤0.01% | 4115 |
|
|
2025
Q1 | $131K | Buy |
240,244
+16,329
| +7% | +$8.87K | ﹤0.01% | 3944 |
|
|
2024
Q4 | $187K | Buy |
223,915
+129,529
| +137% | +$108K | ﹤0.01% | 3939 |
|
|
2024
Q3 | $45.6K | Sell |
94,386
-31,075
| -25% | -$15K | ﹤0.01% | 4039 |
|
|
2024
Q2 | $220K | Buy |
+125,461
| New | +$220K | ﹤0.01% | 3913 |
|
|
2024
Q1 | – | Sell |
-10,850
| Closed | -$34.4K | – | 4274 |
|
|
2023
Q4 | $34.4K | Buy |
10,850
+321
| +3% | +$1.02K | ﹤0.01% | 4185 |
|
|
2023
Q3 | $47.1K | Hold |
10,529
| – | – | ﹤0.01% | 4158 |
|
|
2023
Q2 | $5.97K | Sell |
10,529
-44,476
| -81% | -$25.2K | ﹤0.01% | 4355 |
|
|
2023
Q1 | $50.3K | Hold |
55,005
| – | – | ﹤0.01% | 4194 |
|
|
2022
Q4 | $56.7K | Hold |
55,005
| – | – | ﹤0.01% | 4218 |
|
|
2022
Q3 | $99K | Buy |
55,005
+5,582
| +11% | +$10K | ﹤0.01% | 4196 |
|
|
2022
Q2 | $95K | Buy |
49,423
+38,894
| +369% | +$74.8K | ﹤0.01% | 4233 |
|
|
2022
Q1 | $87K | Hold |
10,529
| – | – | ﹤0.01% | 4430 |
|
|
2021
Q4 | $77K | Hold |
10,529
| – | – | ﹤0.01% | 4440 |
|
|
2021
Q3 | $71K | Sell |
10,529
-848
| -7% | -$5.72K | ﹤0.01% | 4377 |
|
|
2021
Q2 | $57K | Sell |
11,377
-40,638
| -78% | -$204K | ﹤0.01% | 4302 |
|
|
2021
Q1 | $184K | Sell |
52,015
-149
| -0.3% | -$527 | ﹤0.01% | 4074 |
|
|
2020
Q4 | $154K | Sell |
52,164
-1,127
| -2% | -$3.33K | ﹤0.01% | 4023 |
|
|
2020
Q3 | $191K | Buy |
53,291
+606
| +1% | +$2.17K | ﹤0.01% | 3858 |
|
|
2020
Q2 | $221K | Buy |
52,685
+15,064
| +40% | +$63.2K | ﹤0.01% | 3772 |
|
|
2020
Q1 | $112K | Buy |
37,621
+13,843
| +58% | +$41.2K | ﹤0.01% | 3839 |
|
|
2019
Q4 | $119K | Buy |
+23,778
| New | +$119K | ﹤0.01% | 3999 |
|